Friday, 16 October 2026European Markets

POLARIS MEDIA And MAROC TELECOM Have A High Dividend Yield And Return On Equity In The Communication Services Sector.

Loading stream...

(vianews) - polaris media (pol.ol) is among this list of stock assets with the highest dividend rate and return on equity on the communication services sector.

financial asset price forward dividend yield return on equity
polaris media (pol.ol) kr55.50 2.8% 0.47%
maroc telecom (iam.pa) €8.60 2.13% 36.98%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. polaris media (pol.ol)

2.8% forward dividend yield and 0.47% return on equity

polaris media asa operates as a media house and printing company in norway and sweden. the company provides digital advertising services. it also prints group and external newspapers, including editorial supplements, advertising supplements and newspapers, civil prints, and other magazines/supplements. in addition, the company distributes newspapers, as well as parcels, mails, and food deliveries. the company was founded in 2008 and is headquartered in trondheim, norway.

earnings per share

as for profitability, polaris media has a trailing twelve months eps of kr0.27.

pe ratio

polaris media has a trailing twelve months price to earnings ratio of 205.56. meaning, the purchaser of the share is investing kr205.56 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.47%.

moving average

polaris media's worth is higher than its 50-day moving average of kr52.50 and higher than its 200-day moving average of kr50.89.

earnings before interest, taxes, depreciation, and amortization

polaris media's ebitda is 1.05.

more news about polaris media.

2. maroc telecom (iam.pa)

2.13% forward dividend yield and 36.98% return on equity

itissalat al-maghrib (iam) s.a., together with its subsidiaries, provides various telecommunication services in morocco and internationally. it offers mobile, fixed-line, internet, and fixed-line broadband telecommunication services, as well as sells mobile terminals, broadband equipment, and connected objects and accessories. the company was founded in 1998 and is based in rabat, morocco. as of october 28, 2021, itissalat al-maghrib (iam) s.a. operates as subsidiary of emirates telecommunications group company pjsc.

earnings per share

as for profitability, maroc telecom has a trailing twelve months eps of €0.53.

pe ratio

maroc telecom has a trailing twelve months price to earnings ratio of 16.23. meaning, the purchaser of the share is investing €16.23 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.98%.

yearly top and bottom value

maroc telecom's stock is valued at €8.60 at 21:30 est, way under its 52-week high of €10.40 and way higher than its 52-week low of €7.10.

dividend yield

as maintained by morningstar, inc., the next dividend payment is on sep 4, 2023, the estimated forward annual dividend rate is 0.2 and the estimated forward annual dividend yield is 2.13%.

more news about maroc telecom.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com